EUVIMEDEUVIMED entdecken
Crossref

The elusive BAP1 mutation in pediatric melanocytic tumors

Danna Moustafa iD, Mia A Mologousis iD, Lyn M Duncan, Elena B Hawryluk iD

Pediatric Dermatology · 2024

DOI: 10.1111/pde.15705 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Dermatology, 2024. Verfasst von Danna Moustafa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Combined Dermatology Residency Training Program, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Ubiquitin Thiolesterase, Skin Neoplasms, Tumor Suppressor Proteins, Mutation. Die Arbeit nennt 10 Literaturangaben. Gefördert von: 2019 PeDRA Research Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous BAP1‐ inactivated melanocytomas (BIM) are melanocytic proliferations defined histopathologically by an epithelioid, predominantly dermal melanocytic proliferation with loss of BAP1 , and have been largely characterized in adult patients but less well‐described in pediatric cohorts. BIM share overlapping histological features with those seen in Spitz nevi; however, unlike Spitz nevi, the majority of BIM carry both BAP1 and BRAF V600E mutations. This study investigated the potential overlap of BIMs with pediatric Spitz nevi by performing immunohistochemical staining of BAP1 and BRAF V600E on pediatric melanocytic tumors with banal Spitz and dermal features. None of the stained tumors in our study exhibited the concurrent BAP1 loss and BRAF V600E positivity that are characteristic of adult BIM, suggesting that this is a low‐frequency mutation among banal tumors in the pediatric population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin ThiolesteraseSkin NeoplasmsTumor Suppressor ProteinsMutationNevus, Epithelioid and Spindle CellHumansChildMaleFemaleMelanomaAdolescentChild, PreschoolProto-Oncogene Proteins B-rafImmunohistochemistry

Stichwörter der Autor:innen

BAP1 proteinBAP1‐inactivated melanocytomaBAPomaBRAFSpitz nevusdermal nevuspediatric melanomauveal melanoma

Substanzen

BAP1 protein, humanUbiquitin ThiolesteraseTumor Suppressor ProteinsBRAF protein, humanProto-Oncogene Proteins B-raf

Autor:innen und Institutionen

  • Harvard Combined Dermatology Residency Training Program, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Tufts University School of Medicine, Boston, Massachusetts, USA.
  • Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Danna Moustafa, Mia A Mologousis, Elena B Hawryluk

Förderung

  • 2019 PeDRA Research Award

Zitieren

APA

Moustafa, D., Mologousis, M. A., Duncan, L. M., & Hawryluk, E. B. (2024). The elusive BAP1 mutation in pediatric melanocytic tumors. Pediatric Dermatology. https://doi.org/10.1111/pde.15705

Vancouver

Moustafa D, Mologousis MA, Duncan LM, Hawryluk EB. The elusive BAP1 mutation in pediatric melanocytic tumors. Pediatric Dermatology. 2024. doi:10.1111/pde.15705

BibTeX
@article{Moustafa2024,
  author = {Moustafa, Danna and Mologousis, Mia A and Duncan, Lyn M and Hawryluk, Elena B},
  title = {The elusive BAP1 mutation in pediatric melanocytic tumors},
  journal = {Pediatric Dermatology},
  year = {2024},
  doi = {10.1111/pde.15705}
}
Kostenlos starten →